Istaroxime是一款潜在“first-in-class”疗法,具有双重作用机制,旨在改善心脏收缩和舒张...查看全文
$Windtree疗法(WINT)$ 内部交易: 2020-10-28,总裁 and CEO,Fraser Craig ,买入,250普通股, $6.56
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021886 Size: 14 KB 网页链接
$Windtree疗法(WINT)$ 内部交易: 2020-10-23,Director,Huang James ,买入,1000普通股, $6.67
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021666 Size: 6 KB 网页链接
$Windtree疗法(WINT)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021655 Size: 15 KB 网页链接
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021048 Size: 5 KB 网页链接
$Windtree疗法(WINT)$ 内部交易: 2020-10-08,SVP & COO,Curtis Eric ,买入,500普通股, $5.27
$Windtree疗法(WINT)$ 内部交易: 2020-10-07,总裁 and CEO,Fraser Craig ,买入,250普通股, $5.17
$Windtree疗法(WINT)$ 内部交易: 2020-10-07,SVP & CFO,Hamill John P. ,买入,1000普通股, $5.27
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021001 Size: 5 KB 网页链接